Pseudomonas aeruginosa is one of the six multi-drug-resistant pathogens (ESKAPE) considered by the World Health Organization (WHO) as an entire group for which the development of novel antibiotics is urgently needed. In the United States (US) and within the last several...
Pseudomonas aeruginosa is a major cause of nosocomial infections. This organism shows a remarkable capacity to resist antibiotics, either intrinsically (because of constitutive expression of β-lactamases and efflux pumps, combined with low permeability of the outer-membrane) or following acquisition of ...
Pseudomonas aeruginosais an opportunistic bacteria that causes a variety of infections. 铜绿假单孢菌是一种机会致病菌,可以导致很多种类型的感染. 互联网 Pseudomonas aeruginosawas cultured from sputum. 痰液培养出铜绿假单胞菌. 互联网 To investigate the distribution of imipenem - resistantPseudomonas aerugino...
aeruginosa) and their antibiotic resistance genes (ARGs) in aquatic settings and the alternative treatment ways. P. aeruginosa in a various aquatic environment have been identified as contaminants with impacts on human health and the environment. P. aeruginosa resistance to multiple antibiotics, such ...
Pseudomonas aeruginosa (P. aeruginosa) is a Gram-negative opportunistic pathogen that infects patients with cystic fibrosis, burn wounds, immunodeficiency, chronic obstructive pulmonary disorder (COPD), cancer, and severe infection requiring ventilation,
f, The biodistribution of bismuth in mice after treatment by the intranasal administration of 100 mg/kg CBS. g, Proposed the mechanism of action for the synergy of bismuth with antibiotics. Bismuth restores the susceptibility of P. aeruginosa to antibiotics through iron deprivation by interacting...
biofilm; nanoparticles; nickel; nickel oxide; Pseudomonas aeruginosa; Staphylococcus aureus; eDNA Graphical Abstract1. Introduction Nanoparticles have been used as antibacterial agents in medicine for thousands of years [1]. In the 20th century, organic antibiotics were discovered and replaced nanoparticles...
Keywords: P. aeruginosa;COVID-19;collateral effect;antibiotics;antimicrobial stewardship
Pseudomonas aeruginosa,CP-CRPA), makes special proteins that prevent most available antibiotics from working. That includes carbapenems, powerful antibiotics which are prescribed when no other treatment has worked. CP-CRPA is also able to share its genetic code with other bacteria, kind of like shar...
aeruginosa. Appropriate antibiotics were used for selection as indicated in Supplementary Table 3. To create markerless in-frame deletion or mutagenesis, conjugants with the deletion cassette integrated at the target loci were counter-selected on low-salt lysogeny broth agar plates supplemented with...